ReviewFrontiers in oncology2025
Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.
Minhan Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it